Cortancyl

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cortancyl

What is Cortancyl?

Cortancyl is a synthetic corticosteroid medication that contains the active substance prednisone. It belongs to a class of drugs known as glucocorticoids, which are designed to mimic the effects of hormones naturally produced by the adrenal glands.

Mechanism of Action

Prednisone, the active component of Cortancyl, works primarily by modulating the body's immune response and reducing inflammation. When the body experiences certain diseases or conditions, the immune system may become overactive or trigger excessive inflammatory processes. Cortancyl acts on cellular receptors to suppress the production of inflammatory mediators, thereby helping to control swelling, redness, and pain associated with various medical conditions.

Therapeutic Use

Cortancyl is utilized across a wide range of medical specialties due to its potent anti-inflammatory and immunosuppressive properties. It is commonly used to manage chronic and acute conditions, including:

  • Allergic Reactions: Treatment of severe allergic states that do not respond to conventional treatments.
  • Autoimmune Disorders: Management of conditions where the immune system attacks the body's own tissues, such as systemic lupus erythematosus or certain types of hepatitis.
  • Dermatological Diseases: Control of severe inflammatory skin conditions.
  • Hematological Disorders: Treatment of certain blood-related issues and acquired hemolytic anemia.
  • Respiratory Conditions: Management of inflammatory diseases affecting the lungs and airways.
  • Rheumatology: Treatment of inflammatory joint disorders, including rheumatoid arthritis and various forms of arteritis.

Beyond these applications, Cortancyl is also used in transplant medicine to help prevent organ rejection and in oncology as part of specific chemotherapy regimens to treat certain types of cancer, such as leukemia and lymphoma.

What side effects are possible with Cortancyl?

Possible Side Effects and Safety Information

The safety profile for Cortancyl (Prednisolone Acetate) is formally documented according to standard regulatory classifications, reflecting its function as a systemic glucocorticoid. Adverse reactions are grouped by the physiological system affected and are classified by frequency, such as Common or Not Known (incidence cannot be estimated from available data).

Key Regulatory Safety Classifications

Classification Detail Affected Organ Systems
Metabolic and Endocrine Weight gain, fluid retention, hyperglycemia, and suppression of the hypothalamic-pituitary-adrenal (HPA) axis
Musculoskeletal Osteoporosis, muscle weakness (myopathy), and aseptic necrosis
Ophthalmic Posterior subcapsular cataracts and glaucoma (increased intraocular pressure)
Gastrointestinal Risk of peptic ulceration, which may be complicated by hemorrhage or perforation

Serious Adverse Reactions and Contextual Patterns

The official safety information highlights certain clinically significant events, including adrenocortical insufficiency upon cessation of prolonged therapy, which is classified as a serious adverse reaction. Severe psychiatric reactions, such as psychosis or severe depression, are also documented.

Time-related patterns are critical; many serious and common adverse reactions, such as osteoporosis and cataract formation, are officially associated with long-term exposure and higher doses. Conversely, secondary adrenocortical insufficiency is a risk associated with withdrawal following extended use.

Regulatory documents include specific safety notes for certain patient populations. For pediatric patients, risks include suppression of growth and development. Older adults may face increased risk for complications like osteoporosis and hypertension.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile distinguishes between acute ingestion and chronic overexposure. Acute overdose of prednisolone is not expected to produce life-threatening symptoms. The primary concern for overexposure stems from chronic, high-dose administration, which leads to documented signs of systemic hypercorticism (a Cushingoid state).

Manifestations of chronic overexposure include clinical changes such as hypertension, fluid and salt retention, and electrolyte disturbances like hypokalemia. Severe psychological symptoms, including depressed mood or suicidal ideation, are also documented effects requiring medical assessment. Furthermore, the risk of a pheochromocytoma crisis has been reported with systemic corticosteroid use.

Mandated Emergency Actions

Immediate medical help is strictly required for critical symptoms. Emergency services must be contacted if an individual exhibits signs of collapse, seizures (convulsions), trouble breathing, or unresponsiveness. It is also mandated to contact a poison control helpline immediately.

Regulatory guidance confirms that no specific antidote is available. Management is focused on providing symptomatic and supportive treatment. Monitoring requirements include close observation of blood pressure and serum electrolyte levels. Additionally, infants born to mothers who received substantial doses require careful monitoring for documented risks such as hypoadrenalism.

Therapeutic Uses of Cortancyl

Cortancyl is commonly used across a wide range of conditions characterized by periods of heightened symptoms, which require supportive symptomatic assistance. The medicine is applicable within clinical settings that involve acute or disruptive symptom patterns, often used during phases when symptoms become more noticeable.

It is relevant for easing symptoms related to various conditions presenting with systemic or localized discomfort, including flare-ups of Lupus and Rheumatoid Arthritis, Inflammatory Bowel Diseases, acute asthma exacerbations, and non-infectious eye inflammation. The medication provides support that helps ease the overall symptom burden by addressing symptom clusters that may become intense or disruptive, such as severe swelling, pain, and restricted breathing. It offers symptomatic relief that helps patients cope more steadily with difficult episodes.

“Applied in scenarios where additional management of discomfort is required, this support assists with maintaining functional stability.”


Quick Fact: Symptomatic Support for Inflammation & Immune-Related Discomfort

Symptom Type Example Context Patient Benefit
Systemic Swelling & Pain Autoimmune flare-ups Eases the overall symptom load.
Acute Respiratory Distress Asthma exacerbations Assists with managing breathing distress.
Ocular Inflammation Symptom management after surgery Supports day-to-day comfort.

Eligibility and Restrictions for Use

Who Can and Cannot Use Cortancyl?

Cortancyl (prednisolone) eligibility is strictly defined by regulatory documents, which establish clear criteria for use.

Absolute Contraindications

Use is contraindicated in patients with active systemic fungal infections and those with a known hypersensitivity to prednisolone or any component of the formulation. The medicine is also prohibited for patients with cerebral malaria.

Restrictions and Conditions for Use

Eligibility is restricted based on immune status and specific health conditions. The medicine must be used with caution in patients with latent infections, such as tuberculosis, and specific viral conditions, including active ocular herpes simplex. Conditional use applies to patients with metabolic and organ vulnerabilities, requiring caution for those with hepatic or renal impairment, hypertension, diabetes mellitus, and specific gastrointestinal disorders such as active peptic ulcer.

Age and Reproductive Status

Use is established for adults and pediatric patients, but the long-term treatment of children requires careful observation of growth and development, as stated in regulatory labels. Use in older adults mandates cautious dose selection due to common declines in organ function. Use during pregnancy and lactation is conditional, requiring a formal assessment of potential benefit versus documented hazard.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cortancyl’s official interaction profile is defined primarily by pharmacokinetic and pharmacodynamic interactions documented in regulatory sources, structuring the requirements for co-administration.

Metabolic and Exposure Alterations

The medicine's clearance is significantly mediated by the CYP 3A4 enzyme. CYP 3A4 Inducers, such as rifampin or phenytoin, may accelerate metabolism, which can decrease Cortancyl's systemic exposure. Conversely, CYP 3A4 Inhibitors, including ketoconazole or macrolide antibiotics, may decrease clearance, resulting in higher plasma concentrations and a greater risk of corticosteroid effects. Estrogens (including oral contraceptives) may also decrease metabolism, thereby increasing the corticosteroid effect.

Pharmacodynamic Interactions and Restrictions

The interaction profile details several key risk associations. The combination with Antidiabetic Agents may counteract their effectiveness by increasing blood glucose levels. Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) results in an increased, documented risk of gastrointestinal side effects. Furthermore, the combination of Cortancyl with Fluoroquinolones carries an increased risk of tendon rupture, a risk noted to be especially relevant in the elderly population. A formal restriction applies to immunization: live or live attenuated vaccines are contraindicated in individuals receiving immunosuppressive doses of the corticosteroid.

Procedural Constraints

The official label states the medication should be taken with food or milk to mitigate gastrointestinal irritation. Additionally, the co-administration with Anticholinesterase agents carries a risk of severe weakness; the regulatory advice is that these agents should ideally be withdrawn at least 24 hours before starting Cortancyl therapy.

Mechanism of Action

How Cortancyl Works

Cortancyl (Prednisolone) modulates biological responses by acting as an agonist for the Glucocorticoid Receptor (GR), a protein found inside nearly all cells. The drug-receptor complex translocates to the nucleus where it alters gene expression through two primary genomic mechanisms: Transrepression and Transactivation.

Transrepression involves the complex directly suppressing master transcription factors like NF-κB and AP-1, thereby interfering with the genetic instruction set for creating inflammation. Simultaneously, Transactivation increases the expression of anti-inflammatory proteins, such as Annexin-A1 (Lipocortin-1). Annexin-A1 acts as an inhibitor of the enzyme Phospholipase A2 (PLA2), which modifies the early molecular steps that produce prostaglandins and leukotrienes.

This concerted molecular action results in systemic modulation of the immune and inflammatory response. Physiologically, this mechanism constrains mediator activity, leading to a reduction in vascular dilation, capillary leakage, and subsequent fluid accumulation. The drug also suppresses the Hypothalamic-Pituitary-Adrenal (HPA) axis via negative feedback, temporarily inhibiting endogenous cortisol production.

Dosage and Administration Information

Cortancyl, which contains prednisolone, is officially administered via two primary routes based on the formulation type. For systemic effects, it is taken orally as a tablet or suspension. For localized effects on the eye, an ophthalmic suspension or solution is used topically.

Systemic oral use is governed by a flexible dosing schedule. Initial adult doses typically range from 5 mg to 60 mg of prednisolone per day, moving to a lower maintenance dose generally between 2.5 mg and 15 mg daily. The total dose is often taken once a day in the morning or may be divided. Oral doses are required to be taken with food, such as immediately after breakfast, to reduce potential irritation of the digestive tract.

For topical ophthalmic use, the administration involves 1 to 2 drops 2 to 4 times per day, with the frequency potentially increased hourly during the initial 24 to 48 hours for acute cases. Ophthalmic suspensions must be shaken well before each application. A specific procedural instruction requires the removal of soft contact lenses before administration, with reinsertion delayed for at least 15 minutes.

The duration of therapy dictates the withdrawal process. Long-term systemic use, generally defined as exceeding 3 weeks, mandates a gradual dose tapering protocol. In contrast, abrupt cessation may be permitted for short-term courses. Dosage for pediatric patients is individualized based on clinical response, while older adults are generally instructed to use the lowest effective dose for the minimum period necessary.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cortancyl

The research evidence overview for Cortancyl (prednisolone acetate) examines data derived from multiple study types, including controlled clinical trials and systematic reviews. This evidence primarily describes the patterns observed when the compound was evaluated in various conditions characterized by fluctuating or episodic manifestations.


Evidence for Managing Acute Symptoms

Research (RCTs, systematic reviews) has centered on studies conducted during periods of increased symptom activity, such as acute asthma flare-ups in adults and children. These studies research examined short-term changes in lung function markers and relapse rates. A key limitation is the limited information for long-term outcomes regarding the effects of repeated short courses over many years.

For Inflammatory Bowel Disease (IBD), meta-analyses explored its role during the initial induction phase, measuring clinical remission and reduction of acute physical discomfort. This indicates that the evidence is limited to short-term research scenarios only, as it provides limited insight into maintaining remission over long periods.


Evidence for Autoimmune Disease and Topical Use

Research exploring systemic use in autoimmune conditions like Lupus and Rheumatoid Arthritis consists of long-term observational cohort studies tracking disease activity markers and cumulative drug exposure. The evidence is limited in directly establishing a causal relationship between long-term dosing patterns and specific patient outcomes, and comparative evidence is lacking against newer therapies.

For the topical use in post-operative eye inflammation, Randomized Controlled Trials was observed in adult and pediatric patients following cataract surgery. While studied for this indication, findings were mixed regarding the consistency of inflammation clearance due to study design variability, and certainty remains low for some specific endpoints.


Long-Term Data and Research Uncertainty

The research landscape continues to address several areas of uncertainty. Evidence is limited regarding the long-term impact of cumulative exposure for acute, episodic use. Data for certain groups remain insufficient, particularly for pregnant populations or patients with certain comorbid conditions not fully represented in the main trials. The results apply only to the populations studied, meaning the applicability of the findings to patients outside the trial criteria is not directly established by research.

Key Studies & References Prednisone - StatPearls - NCBI Bookshelf - NIH (General Drug Monograph)

Frequently Asked Questions (FAQ)

Common questions about Cortancyl (FAQ)


Q: Is Cortancyl a strong drug?

Regulatory information classifies the active ingredient prednisolone as a potent synthetic glucocorticoid, which belongs to the corticosteroid class of medicines. This designation indicates a powerful ability to modulate the body's inflammatory and immune responses. Its use is reserved for conditions requiring this level of systemic action.


Q: Is Cortancyl known to cause weight gain?

Weight gain is listed in official product information as a common, documented side effect associated with corticosteroid use. This increase in weight may be linked to an increase in appetite and fluid retention in the body.


Q: What should I do if I forget to take my Cortancyl dose?

Official guidance for once-daily dosing describes taking the missed dose as soon as it is remembered, provided it is still on the same day. Regulatory guidance describes that if the dose is remembered only on the next day, the missed dose is typically skipped, and the regular schedule is resumed. This approach is described to align with the plan established by the prescribing healthcare provider.


Q: Is it safe to drink alcohol while taking Cortancyl?

Regulatory documents state that co-administration with alcohol has been associated with an increased risk of certain gastrointestinal side effects. Specifically, there is a documented risk of stomach irritation and potential gastrointestinal bleeding.


Q: Do I need to change my diet while taking Cortancyl?

Official guidance often suggests following a diet that is low in sodium, or salt, and high in essential minerals like calcium and potassium. This dietary modification may help mitigate specific potential side effects of steroid use, such as fluid retention and bone weakening.


Q: Is there a risk of developing diabetes while using Cortancyl?

Prednisolone can cause blood sugar levels to rise by interfering with how insulin works in the body. If blood sugar increases in a person without pre-existing diabetes while taking the medication, this increase is a documented physiological response to steroid use.


Q: Is Cortancyl safe for use during pregnancy or while breastfeeding?

Official information describes that use during pregnancy is conditional, requiring a formal assessment of potential benefits versus documented hazards. For breastfeeding, official sources generally advise against its use when the person is taking doses higher than 5 mg per day.


Q: What is the difference between taking Cortancyl once a day versus multiple times?

Taking the total daily dose once in the morning is a common recommendation intended to align the drug's activity with the body's natural release of the hormone cortisol. This dosing pattern is thought to help minimize the suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis, which is the body's internal stress response system.


Q: What common foods or supplements interact with Cortancyl?

Official product information states that there is limited available evidence regarding the safe co-administration of the medicine with most herbal remedies and dietary supplements. Official sources note that due to limited data, co-administration of most herbal remedies and supplements requires careful consideration by a healthcare provider.


Q: Does Cortancyl affect how my body heals from cuts or injuries?

Slower wound healing is a documented adverse reaction listed in regulatory documents for systemic corticosteroid use. This is a documented effect of the drug's systemic use.


Q: Is it possible to become dependent on Cortancyl?

The drug is associated with suppression of the HPA axis, which means the body may temporarily stop producing its own natural steroid hormones. For this reason, a gradual dose reduction, known as tapering, is used to allow natural hormone function to safely return.


Q: What happens when I stop taking Cortancyl?

Abrupt discontinuation after prolonged use carries a risk of acute adrenal insufficiency or a steroid withdrawal syndrome. Documented symptoms of withdrawal include joint pain, fever, headaches, lethargy, anorexia, and weight loss.


Q: Can I take Cortancyl if I have a history of stomach ulcers?

A history of gastrointestinal disorders, such as active or latent peptic ulcers, is listed in official documents as a condition requiring caution or conditional use. This is because the drug itself carries a documented risk of causing peptic ulceration.


Q: What is the longest amount of time Cortancyl is typically used for?

Official information notes that there is no set limit on the duration of use. The length of treatment is determined by the specific medical condition being addressed, ranging from short-term for acute issues to longer-term for chronic diseases, and is always limited by the emergence of side effects.


Q: What research is currently being done on new uses for Cortancyl?

Evidence from sources that track clinical trials indicates ongoing research is examining the drug’s role in various areas. These include support during cancer treatment and symptom improvement for specific chronic diseases.


Q: Can Cortancyl cause vision changes or affect my eyes?

Official safety information documents adverse reactions that include documented risks of cataracts and glaucoma, as well as vision changes. These changes can include foggy or cloudy vision and problems with glare.


Q: Why are people sometimes given high doses of Cortancyl for a short time?

High-dose, short-term use is typically administered to rapidly suppress symptoms during an acute exacerbation, or flare-up, of an inflammatory condition. This approach is used for acute conditions that require a quick, potent anti-inflammatory action.


Q: Does Cortancyl affect kidney or liver function?

Official product labels note that the drug must be used with caution in patients who already have pre-existing hepatic (liver) or renal (kidney) impairment. This is because these organs are involved in processing and clearing the medication from the body.


Q: Do different brands of the drug (like 'Brand A' vs 'Cortancyl') have the same effects?

Generic versions of the active ingredient, prednisolone, are required by regulatory bodies like the FDA to demonstrate bioequivalence. This means that a generic product must show it releases the same amount of the drug into the bloodstream over the same period as the branded product to be considered therapeutically equivalent.


Q: What are the risks of infection while taking Cortancyl?

The drug's function as an immunosuppressant means it can modulate the immune system, thereby increasing the body's susceptibility to infections. Furthermore, the drug can potentially make the clinical presentation of an infection less obvious or harder to detect.


Q: Can Cortancyl be taken while traveling across time zones?

Official guidance for systemic steroid therapy suggests that adjustments to the dosing schedule are generally advised when traveling across multiple time zones. This is done to align the dose timing with the new time zone and help prevent the risk of adrenal insufficiency.


Q: Why is Cortancyl sometimes prescribed as part of treatment for cancer?

The drug is used in oncology treatment for several reasons, including to decrease inflammation, reduce swelling around tumors, and manage certain cancer-related symptoms. It may also be used as a component of specific chemotherapy regimens.


Q: Does Cortancyl affect cholesterol levels?

Official information indicates that corticosteroids may lead to a potential increase in cholesterol and triglyceride levels in the blood. This effect is generally considered reversible once the treatment is reduced or stopped.


Q: How does Cortancyl affect blood sugar levels in people who don't have diabetes?

Steroid medication frequently causes a temporary increase in blood sugar levels, even in people without a known history of diabetes. This elevation typically resolves once the steroid medication has been discontinued.


Q: Is there a generic version of Cortancyl available?

Generic versions of the active ingredient prednisolone (acetate or sodium phosphate) are officially approved and available from regulatory bodies like the FDA. These generics contain the same active medicinal substance as the branded product.


Q: Why is it important to carry an identification card if taking Cortancyl long-term?

Patients on long-term therapy are officially advised to carry a steroid treatment card. This card informs healthcare providers in an emergency situation (such as trauma, surgery, or serious illness) that the patient may need supplementary steroid treatment due to HPA axis suppression.


Q: Can Cortancyl cause mood changes or affect emotions?

Mild mood changes and psychiatric effects are documented side effects listed in official safety information. These can include feelings of anxiety, restlessness, or depression, with the intensity potentially increasing with higher doses.


Q: Does Cortancyl affect vaccinations or my immune response?

Therapeutic doses of glucocorticoids are known to cause immunosuppression, which modulates immune function. Official guidance states that the use of live or live attenuated vaccines is contraindicated in individuals receiving immunosuppressive doses of the corticosteroid.


Q: What are the long-term effects of taking Cortancyl?

Long-term exposure is formally associated with the risk of several serious effects. These include osteoporosis (weakening of bones), posterior subcapsular cataract formation, and the potential development of Cushing's Syndrome.


Q: Can Cortancyl affect my sleep or energy levels?

Side effects documented in official information can include problems sleeping, such as insomnia, and feeling restless. Taking the dose in the morning is a general recommendation intended to help mitigate these effects.


Q: Is it true that Cortancyl can weaken bones?

Osteoporosis, which is bone density loss, is a documented risk associated with long-term use of the medication. This effect results from the drug's influence on calcium absorption and bone breakdown processes in the body.


Q: What is a 'tapering schedule' and why is it used for Cortancyl?

A tapering schedule is the process of gradually reducing the dose over a period of time, which can range from days to months. This process is used to allow the adrenal glands sufficient time to recover and resume natural hormone production, thereby preventing the serious risk of adrenal insufficiency.

How should Cortancyl be stored and disposed of?

How to Store and Dispose of Cortancyl (Prednisolone Acetate)

The storage and disposal requirements for Cortancyl (Prednisolone Acetate) are strictly defined by regulatory labeling to maintain the drug’s stability and safety.


Storage Requirements

Cortancyl must be stored at Controlled Room Temperature, which is defined as 20 to 25 C (68 to 77 F), with excursions permitted up to 30 C. The product must be protected from moisture and kept in a tight container. A mandatory safety instruction is to keep the medicine out of the sight and reach of children.


Disposal Instructions

Disposal of unused or expired Cortancyl must follow official procedures and be performed in accordance with local requirements. Authorities generally recommend utilizing available drug take-back programs. Medicines should not be disposed of via wastewater or routine household waste, unless specifically authorized by local guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cortancyl found in:

A-Z Index: